A new study has found that Pfizer’s COVID-19 oral antiviral pill Paxlovid appears to provide little or no benefit for younger adults. Views: 0
Posts Tagged ‘measurable’
Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit in Adults 40 to 65: Study
August 29th, 2022 Awake Goy